SCHEMBL679523

SCHEMBL679523

O=COC(=O)C(=O)OC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23092535 0.84
SCHEMBL1333026 0.82
SCHEMBL386479 0.79
SCHEMBL2372718 0.79 ALDH1A1 (0.30)
SCHEMBL28842292 0.79
SCHEMBL10596673 0.79
SCHEMBL1698996 0.75
SCHEMBL17092821 0.75
SCHEMBL586697 0.75
SCHEMBL12903932 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110330406-B Catalytic method for alpha-pinene hydration reaction 青岛科技大学 2022-02-22 CN claimed
CN-103420839-A Method for preparing 3-(3,5-di-t-butyl-4-hydroxyphenyl) propionic acid acrylate RIANLON CORP 2013-12-04 CN claimed
CN-101312973-B Indolizine derivatives, process for their preparation and pharmaceutical compositions containing them SANOFI-AVENTIS (FR) 2011-12-28 CN claimed
US-20110283918-A1 COATINGS FROM NATURAL MACROMOLECULES, WITH GAS BARRIER PROPERTIES TAILORED IN SITU, AND RELATED PREPARATION METHOD MIRANTE S.R.L. (IT) 2011-11-24 US claimed
CN-101312973-A Indolizine derivatives, process for their preparation and pharmaceutical compositions containing them SANOFI AVENTIS (FR) 2008-11-26 CN claimed
EP-0941053-A1 SKIN LIGHTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-15 EP claimed
WO-1998019665-A1 SKIN LIGHTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-14 WO claimed
EP-0410946-B1 Decomposition of detrimental substances TANAKA PRECIOUS METAL IND (JP) 1994-05-04 EP claimed
EP-0355628-B1 Process for chemically decontaminating the surface of a metallic construction element of a nuclear power plant SIEMENS AG (DE) 1993-11-10 EP claimed
EP-0136721-A2 Carboxyalkenamidocephalosporins SHIONOGI & CO., LTD. (JP) 1985-04-10 EP claimed
US-20240197843-A1 BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL SYNLOGIC OPERATING COMPANY, INC. (US) 2024-06-20 US disclosed
WO-2024129974-A1 RECOMBINANT BACTERIA FOR USE IN THE TREATMENT OF DISORDERS IN WHICH OXALATE IS DETRIMENTAL SYNLOGIC OPERATING COMPANY, INC. (US) 2024-06-20 WO disclosed
US-20240058269-A1 COMPOSITION OF MATTER COMPRISING LIPOSOMES EMBEDDED IN A POLYMERIC MATRIX AND METHODS OF USING SAME YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-02-22 US disclosed
EP-4313089-A1 BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL Synlogic Operating Company, Inc. (US) 2024-02-07 EP disclosed
US-11839685-B2 Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2023-12-12 US disclosed
CN-87100139-A Process for producing 1, 5-benzothiepine derivative 1987-08-12 CN disclosed
CN-85101892-A Process for preparing novel 1, 5-benzothiazepine derivatives 1987-01-17 CN disclosed
CN-85103395-A Preparation of 1, 5-benzothiazepine * derivatives as platelet aggregation inhibitors 1986-12-10 CN disclosed
CN-85103524-A Process for preparing 1, 5-benzothiazine derivatives 1986-11-05 CN disclosed
US-4053430-A OXALIC ACID ESTERS AMERICAN CYANAMID COMPANY (US) 1977-10-11 US disclosed